Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results

Taysha Gene Therapies, Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
08/25/2023 4 Alam Kamran (CFO) has filed a Form 4 on Taysha Gene Therapies, Inc.
Txns: Sold 33,000 shares @ $2.33, valued at $76.9k
08/16/2023 4 Manning Paul B (10% Owner) has filed a Form 4 on Taysha Gene Therapies, Inc.
Txns: Bought 16,466,667 shares @ $0.9, valued at $14.8M
08/16/2023 4 Stalfort John A III (Director) has filed a Form 4 on Taysha Gene Therapies, Inc.
Txns: Bought 388,889 shares @ $0.9, valued at $350k
Bought 388,889 shares @ $0.9, valued at $350k
Gifted 50,000 shares @ $0
08/16/2023 4 Nolan Sean P. (CEO) has filed a Form 4 on Taysha Gene Therapies, Inc.
Txns: Bought 444,444 shares @ $0.9, valued at $400k
08/16/2023 4 Donenberg Phillip B. (Director) has filed a Form 4 on Taysha Gene Therapies, Inc.
Txns: Bought 111,111 shares @ $0.9, valued at $100k
07/14/2023 4 Session R.A. II (10% Owner) has filed a Form 4 on Taysha Gene Therapies, Inc.
Txns: Sold 80,528 shares @ $0.7082, valued at $57k
Sold 5,344 shares @ $0.7, valued at $3.7k
05/18/2023 4 Nagendran Sukumar (President and Head of R&D) has filed a Form 4 on Taysha Gene Therapies, Inc.
Txns: Bought 5,000 shares @ $0.68, valued at $3.4k
03/08/2023 4 Session R.A. II (10% Owner) has filed a Form 4 on Taysha Gene Therapies, Inc.
Txns: Acquired 251,296 shares @ $0
Disposed/sold 199,500 options to buy @ $1.95, valued at $389k
02/06/2023 4 Alam Kamran (CFO) has filed a Form 4 on Taysha Gene Therapies, Inc.
Txns: Granted 18,691 shares @ $0
Granted 37,384 options to buy @ $1.18, valued at $44.1k
Granted 149,900 options to buy @ $1.18, valued at $176.9k
01/04/2023 4 Nolan Sean P. (CEO) has filed a Form 4 on Taysha Gene Therapies, Inc.
Txns: Granted 1,106,131 options to buy @ $2.26, valued at $2.5M
01/04/2023 4 Nagendran Sukumar (President and Head of R&D) has filed a Form 4 on Taysha Gene Therapies, Inc.
Txns: Granted 790,093 options to buy @ $2.26, valued at $1.8M
08/24/2022 4 Alam Kamran (CFO) has filed a Form 4 on Taysha Gene Therapies, Inc.
Txns: Sold 3,325 shares @ $3.47, valued at $11.5k
08/22/2022 4 Alam Kamran (CFO) has filed a Form 4 on Taysha Gene Therapies, Inc.
Txns: Sold 7,476 shares @ $3.87, valued at $28.9k
Sold 11,482 shares @ $3.75, valued at $43.1k
Sold 9,717 shares @ $3.5, valued at $34k
07/07/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/01/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/22/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/22/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/22/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/22/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/22/2022 4 Reape Kathleen (Director) has filed a Form 4 on Taysha Gene Therapies, Inc.
Txns: Granted 15,500 options to buy @ $2.81, valued at $43.6k
06/22/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/08/2022 4 Alam Kamran (CFO) has filed a Form 4 on Taysha Gene Therapies, Inc.
Txns: Granted 40,000 options to buy @ $6.52, valued at $260.8k
04/08/2022 4 PRASAD SUYASH (CMO and Head of R&D) has filed a Form 4 on Taysha Gene Therapies, Inc.
Txns: Granted 40,325 options to buy @ $6.52, valued at $262.9k
02/25/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/25/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/25/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/08/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/29/2021 4 Manning Paul B (10% Owner) has filed a Form 4 on Taysha Gene Therapies, Inc.
Txns: Bought 2,202 shares @ $13.19, valued at $29k
11/24/2021 4 Manning Paul B (10% Owner) has filed a Form 4 on Taysha Gene Therapies, Inc.
Txns: Bought 20,000 shares @ $12.54, valued at $250.8k
08/20/2021 4 Alam Kamran (CFO) has filed a Form 4 on Taysha Gene Therapies, Inc.
Txns: Sold 11,193 shares @ $17.35, valued at $194.2k
Sold 9,354 shares @ $16.43, valued at $153.7k
Sold 613 shares @ $17.11, valued at $10.5k
Sold 9,746 shares @ $16.7, valued at $162.8k
Sold 2,094 shares @ $17.14, valued at $35.9k
06/21/2021 4 Donenberg Phillip B. (Director) has filed a Form 4 on Taysha Gene Therapies, Inc.
Txns: Granted 15,500 options to buy @ $25.04, valued at $388.1k
06/21/2021 4 Nagendran Sukumar (Director) has filed a Form 4 on Taysha Gene Therapies, Inc.
Txns: Granted 15,500 options to buy @ $25.04, valued at $388.1k
06/21/2021 4 Nolan Sean P. (Director) has filed a Form 4 on Taysha Gene Therapies, Inc.
Txns: Granted 15,500 options to buy @ $25.04, valued at $388.1k
06/21/2021 4 Reape Kathleen (Director) has filed a Form 4 on Taysha Gene Therapies, Inc.
Txns: Granted 15,500 options to buy @ $25.04, valued at $388.1k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy